Keep Talking: US FDA’s Beleaguered Biologics Center Remains Vital To Regenerative Medicine

Advisory committee for Capricor’s deriamocel planned, regenerative medicine advanced therapy designations proliferate for osteoarthritis, and the ranks of dual RMAT/breakthrough therapy designation holders grow.